Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 30 and 80 years old.
- People who have been diagnosed with Parkinson's disease (PD) based on recognised international diagnostic guidelines (Movement Disorders Society criteria).
- People whose Parkinson's disease is at a mild to moderate stage, rated between 1 and 3 on a standard scale used to measure disease progression (Hoehn & Yahr stage).
- The trial is looking to include 10 people whose Parkinson's disease is linked to a specific gene change (LRRK2) and 10 people with Parkinson's disease not linked to a known genetic cause — all participants will have had genetic testing done using specialist methods (NGS panel and MLPA).
- People who are able to understand and agree to take part in the trial by giving informed consent.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have, or have previously had, other conditions affecting the brain or nervous system.
- People who currently have an infection, or who have had one within the past 4 weeks.
- People who have regularly taken anti-inflammatory medicines (such as ibuprofen or similar) or steroid medicines for at least 1 week during the past 12 weeks.
- People who currently have, or within the past 3 years have had, cancer, or a condition where the immune system attacks the body or causes ongoing inflammation.
- People who have a problem with alcohol or drug misuse or dependence.
- People who have any reason they cannot safely have an MRI scan, including fear of enclosed spaces (claustrophobia).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 3333310889
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
1) To identify molecular and clinical markers of LRRK2-related Parkinson's disease through blood markers analysis, deep clinical phenotyping.; 2) To identify molecular and clinical markers of LRRK2-related Parkinson's disease through blood markers analysis, deep clinical phenotyping.; 3) To identify molecular and clinical markers of LRRK2-related Parkinson's disease through blood markers analysis, deep clinical phenotyping.; 4) To identify molecular and clinical markers of LRRK2-related Parkinson's disease through blood markers analysis, deep clinical phenotyping.; 5) To identify molecular and...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.